Status:

ENROLLING_BY_INVITATION

Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients

Lead Sponsor:

Zealand University Hospital

Collaborating Sponsors:

DemensAI ApS (private tech partner, Denmark)

Conditions:

Dementia (Diagnosis)

Alzheimer Dementia (AD)

Eligibility:

All Genders

50+ years

Brief Summary

The goal of this observational study is to develop and test an artificial intelligence (AI) model that can detect signs of dementia and related conditions from speech recordings. The main question is ...

Detailed Description

Background Dementia is a growing public health challenge, and early and accurate diagnosis is essential for effective care and potential future disease-modifying treatments. Current diagnostic pathway...

Eligibility Criteria

Inclusion

  • Age \> 50 years
  • Fluent in Danish
  • Minimum 7 years of schooling
  • For participants from the follow-up cohort:
  • A consensus diagnosis of either AD, VaD, LBD, FTD, MCI or depression established at the memory clinic within 6 months prior to enrollment
  • For participants from the healthy control cohort:
  • No known cognitive impairment or affective disorder

Exclusion

  • Significantly impaired vision or hearing (to the extent that the participant cannot participate in the linguistic AI analysis)
  • Participants unable to give consent
  • Participants from follow-up and new referrals cohort:
  • MMSE score \< 16
  • Participants with multiple diagnoses (eg. mixed dementia or AD with concurrent depression)
  • For participants from the new referrals cohort:
  • Participants falling outside of the six categories included in the study (AD, VaD, LBD, FTD, MCI, Depression)
  • Participants where it is obvious at baseline that they will not fall within the above categories (can be excluded before clinical consensus diagnosis is given)
  • For participants from the healthy control cohort:
  • MMSE \<26 and ACE \<90
  • GDS score indicating depression (6 or higher)
  • Clinical, laboratory or neuroradiological findings that could affect cognitive functions

Key Trial Info

Start Date :

October 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2028

Estimated Enrollment :

340 Patients enrolled

Trial Details

Trial ID

NCT07200739

Start Date

October 1 2025

End Date

June 1 2028

Last Update

October 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zealand University Hospital

Roskilde, Region Sjælland, Denmark, 4000